Overview
- Cofepris approved private commercialization of Pfizer’s updated mRNA shot, enabling sales through pharmacies, private hospitals and medical vaccinators.
- The formulation, sold as Comirnaty LP.8.1, is described by Pfizer as its most up-to-date vaccine targeting the currently circulating LP.8.1 variant.
- Use is authorized for three groups: ages 6 months to 4 years, 5 to 11 years, and 12 years and older.
- Pricing is set by authorized distributors, with early retail checks showing MXN 948 at San Pablo and MXN 949 at Farmacia del Ahorro.
- Pfizer and health leaders, including David Kershenobich and Armida Zúñiga Estrada, cast the rollout as a public–private collaboration following a documentation-related delay, while the vaccine has been free in the public system since October.